Search

Journals
Title Alimentary Pharmacology and Therapeutics
Title Cancer Chemotherapy & Pharmacology
Publications
Abstract , for the adverse effects seen with other BTK inhibitors. Areas covered: This drug profile covers zanubrutinib clinical pharmacology and the translation of pharmacokinetics (PK) and pharmacodynamics (PD) to clinical efficacy and safety profiles, by highlighting key

Chemoresistance is mediated by ovarian cancer leader cells in vitro.   [10-Sep-2021]

Karimnia N.; Wilson A.L.; Green E.; Matthews A.; Jobling T.W. ; Plebanski M.; Bilandzic M.; Stephens A.N.

Neuroimaging Pharmacopoeia   [2015]

Chandra, Ronil 

Recent advancements in targeting the immune system to treat hypertension.   [25-Sep-2024]

R Muralitharan R.; Marques F.Z.; O'Donnell J.A.

Fibromyalgia: Current diagnosis and management.   [11-Oct-2012]

Guymer E. ; Littlejohn G.

Macrophages and diabetic nephropathy.   [12-Oct-2012]

Tesch G.H.

An approach to managing fibromyalgia.   [18-Oct-2012]

Guymer E.K. ; Littlejohn G.O.
Abstract of treatment efficacy and toxicities. We discuss pharmacological and interventional treatment options and some cancer pain syndromes. DISCUSSION: Management of cancer pain should be proactive and driven by an understanding of pain mechanisms, cancer behaviour
Abstract -invasive, pharmacological and surgical modification of functional orphan neurones as they affect adjacent systems. The Orphan neurone/DA excess hypothesis permits a more comprehensive and defendable interpretation of the interrelationship between Parkinsonism

Discover